Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer

doi:10.3748/wjg.v23.i33.6119

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8683)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

487

WORD

316

HTML

4697

Figures (1-4)

244

Tables (1-3)

236

Sum=5980

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1003

Download

1700

Sum=2703

Sep 7, 2017 (publication date) through Jan 11, 2025

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Sep 7, 2017; 23(33): 6119-6127
Published online Sep 7, 2017. doi: 10.3748/wjg.v23.i33.6119

Open in New Tab Full Size Figure Download Figure

Figure 1 Representative graphs of HE staining (20 ×) of various gastric tissues including dysplasia.

Open in New Tab Full Size Figure Download Figure

Figure 2 Outline of proteomic experimental workflow. SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis; C-HPLC: Capillary-high performance liquid chromatography; QE: Q-exactive; LFQ: Label free quantitative.

Open in New Tab Full Size Figure Download Figure

Figure 3 Immunohistochemical staining of DNA-PKcs (40 ×). A: Normal; B: Mild dysplasia; C: Moderate dysplasia; D: Severe dysplasia; E: Early mucosal cancer.

Open in New Tab Full Size Figure Download Figure

Figure 4 Immunohistochemical staining of ERGIC1 (40 ×). A: Normal; B: Mild dysplasia; C: Moderate dysplasia; D: Severe dysplasia; E: Early mucosal cancer.

Citation: Wang FR, Wei YC, Han ZJ, He WT, Guan XY, Chen H, Li YM. Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer. World J Gastroenterol 2017; 23(33): 6119-6127
URL: https://www.wjgnet.com/1007-9327/full/v23/i33/6119.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i33.6119